Skip to main content
. 2017 Feb 8;58(2):117–126. doi: 10.4111/icu.2017.58.2.117

Fig. 3. Comparison of immunocytochemistry (IHC) scores of both estrogen receptor (ER) subtypes in benign prostatic hyperplasia (BPH) patients vs. normal controls. *Significant difference (p<0.05).

Fig. 3